Live Blog: The FDA Advisory Panel On IMPROVE-IT

This is the CardioBrief Live Blog of the FDA's Endocrinologic and Metabolic Drugs Advisory Committee meeting to discuss the results of the Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT).

Cardiobrief

0

0